INJECTION SITE MUSCLE ATROPHY

This adverse event was reported 32 times

These drugs are most commonly taken by patients reporting INJECTION SITE MUSCLE ATROPHY:

# Drug Count
0 ONABOTULINUMTOXINA 5
1 CABOTEGRAVIR AND RILPIVIRINE 3
2 NALTREXONE 3
3 TIRZEPATIDE 3
4 BOTULINUM TOXIN TYPE A 2
5 CABOTEGRAVIR 2
6 CELECOXIB 2
7 DUPILUMAB 2
8 GLATIRAMER ACETATE 2
9 INCOBOTULINUMTOXINA 2
See all common drugs associated with INJECTION SITE MUSCLE ATROPHY

INJECTION SITE MUSCLE ATROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOMAPACITAN-BECO 1 0.0055
1 CUPRIC CHLORIDE 1 0.0013
2 GIVOSIRAN SODIUM 1 0.0006
3 CABOTEGRAVIR AND RILPIVIRINE 3 0.0005
4 INCOBOTULINUMTOXINA 2 0.0003
5 RILPIVIRINE 2 0.0003
6 CABOTEGRAVIR 2 0.0002
7 PRAZOSIN 1 0.0002
8 BOTULINUM TOXIN TYPE A 2 0.0002
9 ELETRIPTAN HYDROBROMIDE 1 0.0001
See all drugs enriched for association with INJECTION SITE MUSCLE ATROPHY